| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
15,830,000 |
| Market
Cap: |
35.46(M) |
| Last
Volume: |
86,028 |
Avg
Vol: |
76,335 |
| 52
Week Range: |
$1.69 - $11.04 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inotiv is a contract research organization providing drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. Co.'s segments include: contract research services, which provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing; and research products, which designs, develops, manufactures and markets in vivo sampling systems and accessories, physiology monitoring tools, and liquid chromatography and electrochemistry instruments platforms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
52,966 |
52,966 |
72,966 |
| Total Buy Value |
$0 |
$163,981 |
$163,981 |
$445,856 |
| Total People Bought |
0 |
2 |
2 |
3 |
| Total Buy Transactions |
0 |
2 |
2 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
5,123 |
| Total Sell Value |
$0 |
$0 |
$0 |
$58,709 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Moller Claus J |
Affiliate of 10% owner |
– – • |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,946,961 |
2,231,256 |
|
- |
|
| Garrett Michael |
Chief Commercial Officer |
• – – |
2022-09-15 |
4 |
B |
$23.06 |
$23,058 |
D/D |
1,000 |
2,000 |
2.74 |
-67% |
|
| Beattie John Gregory |
Chief Operating Officer |
• – – |
2022-09-09 |
4 |
B |
$22.34 |
$198,826 |
D/D |
8,900 |
51,694 |
2.74 |
-68% |
|
| Davis Gregory Cole |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,275 |
41,958 |
|
- |
|
| Neff R Matthew |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,275 |
65,388 |
|
- |
|
| Cragg Scott |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,275 |
4,715 |
|
- |
|
| Johnson Richard Allen |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,275 |
71,958 |
|
- |
|
| Brown Nigel |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,275 |
4,715 |
|
- |
|
| Beraldi Fernanda |
General Counsel & Secretary |
• – – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Leasure Robert Jr. |
PRESIDENT AND CEO |
• • – |
2022-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
349,315 |
634,531 |
|
- |
|
| Harkness James |
Chief Operating Officer, RMS |
• – – |
2022-03-15 |
4 |
B |
$18.84 |
$765,637 |
D/D |
38,968 |
38,968 |
2.74 |
-19% |
|
| Downing Philip A |
Sr. VP, Preclinical Srvcs. |
• – – |
2022-02-22 |
4 |
B |
$23.97 |
$47,946 |
D/D |
2,000 |
42,195 |
2.74 |
-62% |
|
| Taylor Beth |
VP- Finance & CFO |
• – – |
2022-02-18 |
4 |
B |
$23.07 |
$115,358 |
D/D |
5,000 |
83,875 |
2.74 |
-59% |
|
| Davis Gregory Cole |
Director |
– • – |
2022-02-18 |
4 |
B |
$21.12 |
$86,214 |
D/D |
3,750 |
37,683 |
2.39 |
-59% |
|
| Garrett Michael |
Chief Commercial Officer |
• – – |
2022-02-18 |
4 |
B |
$23.50 |
$23,500 |
D/D |
1,000 |
1,000 |
2.74 |
-59% |
|
| Beattie John Gregory |
Chief Operating Officer |
• – – |
2022-02-18 |
4 |
B |
$23.88 |
$23,879 |
D/D |
1,000 |
42,794 |
2.74 |
-59% |
|
| Pitchford William D |
Chief HR Officer |
• – – |
2022-02-18 |
4 |
B |
$21.12 |
$73,920 |
D/D |
3,500 |
76,174 |
2.74 |
-59% |
|
| Sagartz John E |
Chief Strategy Officer |
• • – |
2022-02-17 |
4 |
B |
$19.95 |
$49,999 |
D/D |
2,506 |
681,030 |
2.81 |
-53% |
|
| Leasure Robert Jr. |
President and CEO |
• • – |
2022-02-17 |
4 |
B |
$23.03 |
$115,131 |
D/D |
5,000 |
285,216 |
2.81 |
-53% |
|
| Davis Gregory Cole |
Director |
– • – |
2022-02-17 |
4 |
B |
$20.57 |
$25,714 |
D/D |
1,250 |
33,933 |
2.39 |
-53% |
|
| Beattie John Gregory |
Chief Operating Officer |
• – – |
2022-02-17 |
4 |
B |
$21.19 |
$97,468 |
D/D |
4,600 |
41,794 |
2.74 |
-53% |
|
| Beattie John Gregory |
Chief Operating Officer |
• – – |
2022-02-16 |
4 |
B |
$23.71 |
$137,524 |
D/D |
5,800 |
37,194 |
2.74 |
-58% |
|
| Taylor Beth |
VP- Finance & CFO |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
78,875 |
|
- |
|
| Sagartz John E |
Chief Strategy Officer |
• • – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
678,524 |
|
- |
|
| Pitchford William D |
Chief HR Officer |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
72,674 |
|
- |
|
177 Records found
|
|
Page 2 of 8 |
|
|
0.12 (5.66%) 
